6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trial. (Q53078833)
Jump to navigation
Jump to search
scientific article published on 12 March 2018
Language | Label | Description | Also known as |
---|---|---|---|
English | 6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trial. |
scientific article published on 12 March 2018 |
Statements
6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trial. (English)
1 reference
Joo-Yong Hahn
1 reference
Young Bin Song
1 reference
Ju-Hyeon Oh
1 reference
Deok-Kyu Cho
1 reference
Jin Bae Lee
1 reference
Joon-Hyung Doh
1 reference
Sang-Hyun Kim
1 reference
Jin-Ok Jeong
1 reference
Jang-Ho Bae
1 reference
Byung-Ok Kim
1 reference
Jang Hyun Cho
1 reference
Il-Woo Suh
1 reference
Doo-Il Kim
1 reference
Hoon-Ki Park
1 reference
Jong-Seon Park
1 reference
Woong Gil Choi
1 reference
Wang Soo Lee
1 reference
Jihoon Kim
1 reference
Ki Hong Choi
1 reference
Taek Kyu Park
1 reference
Joo Myung Lee
1 reference
Jeong Hoon Yang
1 reference
Jin-Ho Choi
1 reference
Seung-Hyuk Choi
1 reference
Hyeon-Cheol Gwon
1 reference
SMART-DATE investigators
1 reference
12 March 2018
1 reference
1 reference
391
1 reference
1274-1284
1 reference
10127
1 reference
Identifiers
1 reference